All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Looking to bolster cash reserves as it continues late-stage development of its lead products, Pain Therapeutics Inc. registered with the SEC for a follow-on stock offering that could raise about $51.6 million. (BioWorld Today)